This year's prescription-drug price hikes may have been a bit less exorbitant than in years past. But they were plenty high enough to hurt American patients — and strengthen resolve in Washington to push back.
This year's prescription-drug price hikes may have been a bit less exorbitant than in years past. But they were plenty high enough to hurt American patients — and strengthen resolve in Washington to push back.